Replies to post #54249 on Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

Hi Steelyeye - I think they will have a full board/uplisting completed before they entertain collaborative agreements with a partner. To me that would be a better bargaining position, especially if some of the prospective board members are from the pharma/biotech industry. That said, concurrently offering a board seat to a prospective suitor during the uplisting/BOD appointment, if simultaneous, is also an attractive bargaining chip.

I think later in the summer/early fall makes sense as I believe it would more than likely involve brilicidin and it appears preliminary data from that study will not be available until that timeframe unless they want to offer a board suit for Kevetrin, the crown jewel in their basket (not that the other jewels are shabby).

[BonelessCat]

And, I agree with this:

I would put the dilemma a bit differently: without an independent board of directors, what will Leo and Krishna have to "give up" in order to get a decent partnership at all? A board seat? Future Royalties %? Plus?

For myself, 3 more people right now making decisions with the power to overrule the current two insiders, doesn't make sense. But later this year it most definitely will make sense because the landscape will be larger and the decisions greater. So I hope you are right that Leo has people interviewed and vetted for when the time is right. Again, with Leo and Menon holding the majority of shares, there are pluses and minuses.

We are at least 6 to 10 months away from any kind of partnership if we trust Leo when he said that he won't license anything until the completion of phase 2 testing. Brilacidin or Brilacidin OM would be closest to that, and if all goes well Brilacidin for ABSSSI would be there in about 8 months. I see no reason for beginning the appointments for an independent board for at least 4 to 6 months.